ATE115956T1 - Furano(2,3-f>isoindole als aldose-reduktase- inhibitoren. - Google Patents
Furano(2,3-f>isoindole als aldose-reduktase- inhibitoren.Info
- Publication number
- ATE115956T1 ATE115956T1 AT91108805T AT91108805T ATE115956T1 AT E115956 T1 ATE115956 T1 AT E115956T1 AT 91108805 T AT91108805 T AT 91108805T AT 91108805 T AT91108805 T AT 91108805T AT E115956 T1 ATE115956 T1 AT E115956T1
- Authority
- AT
- Austria
- Prior art keywords
- aldose reductase
- isoindoles
- furano
- reductase inhibitors
- inhibitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Ophthalmology & Optometry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14246390 | 1990-05-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE115956T1 true ATE115956T1 (de) | 1995-01-15 |
Family
ID=15315903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT91108805T ATE115956T1 (de) | 1990-05-30 | 1991-05-29 | Furano(2,3-f>isoindole als aldose-reduktase- inhibitoren. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5324742A (de) |
EP (1) | EP0459449B1 (de) |
JP (1) | JPH04217684A (de) |
KR (1) | KR910020176A (de) |
AT (1) | ATE115956T1 (de) |
DE (1) | DE69106047T2 (de) |
DK (1) | DK0459449T3 (de) |
ES (1) | ES2069118T3 (de) |
GR (1) | GR3014909T3 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102574854B (zh) | 2009-10-13 | 2014-04-16 | 伊兰科动物健康爱尔兰有限公司 | 大环整合酶抑制剂 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU163443B (de) * | 1970-08-26 | 1973-08-28 | ||
US4337265A (en) * | 1981-08-21 | 1982-06-29 | Ayerst, Mckenna & Harrison Inc. | Cyclohepta[b]pyrrole derivatives |
US4503236A (en) * | 1982-04-19 | 1985-03-05 | Warner-Lambert Company | Antiallergic 4Hfuro[3,2-b]indoles |
FR2533563A1 (fr) * | 1982-09-23 | 1984-03-30 | Adir | Nouveaux derives de la sulfonyluree, leurs procedes de preparation et les compositions pharmaceutiques les renfermant |
HU203238B (en) * | 1984-08-24 | 1991-06-28 | Pfizer | Process for producing antiinflammatory tricyclic oxindole derivatives |
ES2032749T3 (es) * | 1985-11-07 | 1993-03-01 | Pfizer Inc. | Acidos oxoftalazinil-aceticos heterociclicos. |
WO1993012786A1 (en) * | 1986-07-10 | 1993-07-08 | Howard Harry R Jr | Indolinone derivatives |
-
1991
- 1991-03-07 JP JP3068730A patent/JPH04217684A/ja active Pending
- 1991-05-08 US US07/697,009 patent/US5324742A/en not_active Expired - Fee Related
- 1991-05-29 EP EP91108805A patent/EP0459449B1/de not_active Expired - Lifetime
- 1991-05-29 AT AT91108805T patent/ATE115956T1/de not_active IP Right Cessation
- 1991-05-29 DE DE69106047T patent/DE69106047T2/de not_active Expired - Fee Related
- 1991-05-29 ES ES91108805T patent/ES2069118T3/es not_active Expired - Lifetime
- 1991-05-29 DK DK91108805.2T patent/DK0459449T3/da active
- 1991-05-30 KR KR1019910008967A patent/KR910020176A/ko not_active Application Discontinuation
-
1995
- 1995-02-01 GR GR940404067T patent/GR3014909T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR910020176A (ko) | 1991-12-19 |
GR3014909T3 (en) | 1995-05-31 |
JPH04217684A (ja) | 1992-08-07 |
DE69106047D1 (de) | 1995-02-02 |
ES2069118T3 (es) | 1995-05-01 |
DK0459449T3 (da) | 1995-02-20 |
EP0459449A1 (de) | 1991-12-04 |
DE69106047T2 (de) | 1995-06-22 |
US5324742A (en) | 1994-06-28 |
EP0459449B1 (de) | 1994-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE138935T1 (de) | Als süsstoffe brauchbare verbindungen und hir herstellungsverfahren | |
NO955023D0 (no) | Piperidinderivater og fremgangsmåte for fremstilling derav | |
DK0405864T3 (da) | Phospholipase A2-inhibitor, mikroorganismer der producerer inhibitoren og fremgangsmåder til den fremstilling | |
ATE263771T1 (de) | Totalsynthese von acylfulvenen mit antitumorwirkung | |
DK0559533T3 (da) | Fremgangsmåde til fremstilling af beta-lactamderivat og syntetisk mellemprodukt deraf | |
AU3274997A (en) | Intermediates for the preparation of duocarmycin sa and derivatives thereof, and process for the production of the intermediates | |
DK0597423T3 (da) | Azetidinonforbindelse og fremgangsmåde til fremstilling deraf | |
ATE161254T1 (de) | Benzopyranderivat | |
ATE115956T1 (de) | Furano(2,3-f>isoindole als aldose-reduktase- inhibitoren. | |
ES2120498T3 (es) | Nuevo compuesto tetraciclico. | |
FI914525A (fi) | Foerening, anvaendning och framstaellning. | |
DK0874807T4 (da) | Fremgangsmåde til fremstilling af methoximinophenylglyoxylsyrederivater | |
ES2060545A1 (es) | Un procedimiento para producir un derivado de benzo(b)tiofen-5-ilo opticamente activo. | |
ES2074770T3 (es) | Procedimiento de preparacion de derivados de 1,3-dioxano-4,6-diona. | |
DE69323894T2 (de) | Verfahren zur herstellung von provitamin-d-verbindungen | |
DK0565059T3 (da) | Indolderivat | |
PL349388A1 (en) | Method for producing optically active 1-amino-4-(hydroxymethyl)-cyclopent-2-ene derivatives | |
CA2012514A1 (en) | Stabilizers derived from n-hydroxy hindered amines by michael addition reactions | |
YU15596A (sh) | Postupak za sintezu jedinjenja j reduktivnom aminacijom | |
ES8700693A1 (es) | Un procedimiento para producir un nuevo inhibidor de (-d-ma-nosidasa,la manostatina,o su s-oxido | |
DE69025817D1 (de) | 3-Keto-HMG-CoA Reduktase-Inhibitoren | |
EA199800767A1 (ru) | Производные 1(2h)хинолинкарбоновой кислоты, способ их получения и их применение в синтезе веществ, обладающих антибиотическими свойствами |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |